The harder challenge is getting yourself to actually do it when your body is sending no hunger signals at all
With obesity linked to hypertension, dyslipidemia, sleep apnea, cardiovascular disease, fatty liver disease, and kidney complications, GLP-1 drugs have become platform therapies rather than single-indication products
Carew LB, Evarts KG, Alster FA
So, lets go beyond the simple 'yes' and explore precisely why refrigeration for a compound like Lipo C isn't just a suggestion
The study showed a 13% reduction in major adverse cardiovascular events (MACE), a composite endpoint for cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, in patients treated with liraglutide compared with placebo at a mean follow-up of 3.8 years (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.780.97) and a significant reduction in cardiovascular death (HR 0.78, 95% CI 0.660.93)
In this configuration, expression of human GLP1R is restricted to Cre-positive, endogenously Glp1r- expressing neurons in each targeted region (Supplementary Fig
